{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:18:45Z","timestamp":1777616325428,"version":"3.51.4"},"reference-count":48,"publisher":"Society of Nuclear Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.2967\/jnumed.112.119313","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T02:42:50Z","timestamp":1381200170000},"page":"2032-2038","source":"Crossref","is-referenced-by-count":26,"title":["Long-Term Outcome and Toxicity After Dose-Intensified Treatment with <sup>131<\/sup>I-MIBG for Advanced Metastatic Carcinoid Tumors"],"prefix":"10.2967","volume":"54","author":[{"given":"Samer","family":"Ezziddin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timur","family":"Logvinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Alkawaldeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte J.","family":"Yong-Hing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojjat","family":"Ahmadzadehfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Biersack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2013,10,7]]},"reference":[{"key":"2021051712053909000_54.12.2032.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(03)00426-4"},{"key":"2021051712053909000_54.12.2032.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0652-6"},{"key":"2021051712053909000_54.12.2032.3","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0074"},{"key":"2021051712053909000_54.12.2032.4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF03348026","article-title":"The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients","volume":"20","author":"Loh","year":"1997","journal-title":"J Endocrinol Invest."},{"key":"2021051712053909000_54.12.2032.5","first-page":"202","article-title":"[131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma","volume":"35","author":"Hoefnagel","year":"1991","journal-title":"J Nucl Biol Med."},{"key":"2021051712053909000_54.12.2032.6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910215)67:4<922::AID-CNCR2820670411>3.0.CO;2-D"},{"key":"2021051712053909000_54.12.2032.7","first-page":"6147","article-title":"Stability and pharmacokinetics of m-[131I]iodobenzylguanidine in patients","volume":"47","author":"Ehninger","year":"1987","journal-title":"Cancer Res."},{"key":"2021051712053909000_54.12.2032.8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00173043","article-title":"Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry","volume":"21","author":"Wafelman","year":"1994","journal-title":"Eur J Nucl Med."},{"key":"2021051712053909000_54.12.2032.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2004.06.050"},{"key":"2021051712053909000_54.12.2032.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7603-1"},{"key":"2021051712053909000_54.12.2032.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20592"},{"key":"2021051712053909000_54.12.2032.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3496"},{"key":"2021051712053909000_54.12.2032.13","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199207000-00006"},{"key":"2021051712053909000_54.12.2032.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-2022-7"},{"key":"2021051712053909000_54.12.2032.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.098624"},{"key":"2021051712053909000_54.12.2032.16","first-page":"441","article-title":"Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors","volume":"52","author":"Khan","year":"2008","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2021051712053909000_54.12.2032.17","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2009.0672"},{"key":"2021051712053909000_54.12.2032.18","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2009.11.004"},{"key":"2021051712053909000_54.12.2032.19","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-198603000-00002"},{"key":"2021051712053909000_54.12.2032.20","first-page":"77","article-title":"Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours: experience of the National Cancer Institute of Milan","volume":"44","author":"Castellani","year":"2000","journal-title":"Q J Nucl Med."},{"key":"2021051712053909000_54.12.2032.21","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.2001.1132"},{"key":"2021051712053909000_54.12.2032.22","doi-asserted-by":"publisher","DOI":"10.1159\/000111034"},{"key":"2021051712053909000_54.12.2032.23","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.1996.14.6.1829","article-title":"Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors","volume":"14","author":"Taal","year":"1996","journal-title":"J Clin Oncol."},{"key":"2021051712053909000_54.12.2032.24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01309.x"},{"key":"2021051712053909000_54.12.2032.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(02)00273-X"},{"key":"2021051712053909000_54.12.2032.26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604273"},{"key":"2021051712053909000_54.12.2032.27","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnm.0000184941.06123.b9"},{"key":"2021051712053909000_54.12.2032.28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.066"},{"key":"2021051712053909000_54.12.2032.29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2553"},{"key":"2021051712053909000_54.12.2032.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1610-2"},{"key":"2021051712053909000_54.12.2032.31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.8585"},{"key":"2021051712053909000_54.12.2032.32","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012272314550"},{"key":"2021051712053909000_54.12.2032.33","doi-asserted-by":"crossref","first-page":"e13592","DOI":"10.1200\/jco.2012.30.15_suppl.e13592","article-title":"Interim results of an open-label, single-arm trial of ultratrace I-131-iobenguane in patients with metastatic pheochromocytoma\/paraganglioma (Pheo)","volume":"30","author":"Pryma","year":"2012","journal-title":"J Clin Oncol."},{"key":"2021051712053909000_54.12.2032.34","first-page":"1823","article-title":"131I-MIBG therapy of neural crest tumours","volume":"17","author":"Troncone","year":"1997","journal-title":"Anticancer Res."},{"key":"2021051712053909000_54.12.2032.35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF00182305","article-title":"Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine","volume":"21","author":"Sisson","year":"1994","journal-title":"Eur J Nucl Med."},{"key":"2021051712053909000_54.12.2032.36","first-page":"337","article-title":"Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine","volume":"14","author":"Sisson","year":"1988","journal-title":"Eur J Nucl Med."},{"key":"2021051712053909000_54.12.2032.37","first-page":"244","article-title":"Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma","volume":"35","author":"Matthay","year":"1991","journal-title":"J Nucl Biol Med."},{"key":"2021051712053909000_54.12.2032.38","first-page":"280","article-title":"Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma","volume":"35","author":"Lewington","year":"1991","journal-title":"J Nucl Biol Med."},{"key":"2021051712053909000_54.12.2032.39","first-page":"1024","article-title":"Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors","volume":"38","author":"Bongers","year":"1997","journal-title":"J Nucl Med."},{"key":"2021051712053909000_54.12.2032.40","first-page":"703","article-title":"Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors","volume":"26","author":"Forrer","year":"2006","journal-title":"Anticancer Res."},{"key":"2021051712053909000_54.12.2032.41","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0108"},{"key":"2021051712053909000_54.12.2032.42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.616"},{"key":"2021051712053909000_54.12.2032.43","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010415)91:8<1543::AID-CNCR1163>3.0.CO;2-N"},{"key":"2021051712053909000_54.12.2032.44","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-200029058"},{"key":"2021051712053909000_54.12.2032.45","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20466"},{"key":"2021051712053909000_54.12.2032.46","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-4-199402150-00008"},{"key":"2021051712053909000_54.12.2032.47","first-page":"223","article-title":"Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors","volume":"47","author":"Ezziddin","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712053909000_54.12.2032.48","first-page":"660","article-title":"Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model","volume":"47","author":"Madsen","year":"2006","journal-title":"J Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.112.119313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:50:50Z","timestamp":1621281050000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.112.119313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,7]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,2]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.2967\/jnumed.112.119313"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.112.119313","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,7]]}}}